beta-amyloid 40 (Aβ40) antibody and antigen (Recombinant protein)
Diagnostic beta-amyloid 40 (Aβ40) antibodies (anti-beta-amyloid 40, anti-Aβ40) and antigens (recombinant beta-amyloid 40 (Aβ40) protein) for Neurodegenerative diseases Aβ40 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-Aβ40-Ag01 | Beta-amyloid 40 (Aβ40) antigen | $3090.00 |
GMP-h-Aβ40-Ab01 | Anti-human Aβ40 mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-Aβ40-Ab02 | Anti-human Aβ40 mouse monoclonal antibody (mAb) | $1953.00 |
GMP-h-Aβ40-Ab03 | Anti-human Aβ40 human monoclonal antibody (mAb) | $1953.00 |
GMP-h-Aβ40-Ab04 | Anti-human Aβ40 human monoclonal antibody (mAb) | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Pruducts | GMP-h-Aβ40-Ag01 |
Product Name | Beta-amyloid 40 (Aβ40) antigen |
Target/Biomarker | beta-amyloid 40 (Aβ40) |
Alias of Target/Biomarker | AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP |
Expression platform | synthesized |
Isotypes | NA |
Bioactivity validation | beta-amyloid 40 (Aβ40) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation |
Products description | Beta-amyloid 40 (Aβ40) antigen is synthesized |
Purity | Purity: ≥95% (HPLC) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-Aβ40-Ab01,GMP-h-Aβ40-Ab02 |
Product Name | Anti-human Aβ40 mouse monoclonal antibody (mAb) |
Target/Biomarker | beta-amyloid 40 (Aβ40) |
Alias of Target/Biomarker | AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human beta-amyloid 40 (Aβ40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human Aβ40 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Pruducts | GMP-h-Aβ40-Ab03,GMP-h-Aβ40-Ab04 |
Product Name | Anti-human Aβ40 human monoclonal antibody (mAb) |
Target/Biomarker | beta-amyloid 40 (Aβ40) |
Alias of Target/Biomarker | AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Human beta-amyloid 40 (Aβ40) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 40 (Aβ40) antibodies in Aβ40 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human Aβ40 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Reconized/Reactive Species | Human |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Target/Biomarker information
Easily accessible biomarkers are needed for the early identification of individuals at risk of developing Alzheimer's disease (AD) in large population screening strategies. Low plasma Aβ42/40 was associated with more pronounced decline in cognitive function (measured by multiple outcomes) over time. Findings suggest that plasma Aβ42/40 may be used to identify people at risk of cognitive decline, being an alternative to more complex and expensive measures, such as positron emission tomography imaging or cerebrospinal fluid measurement.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.